Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-12-03 18:32:31
Reporting Period:
Accepted Time:
2019-12-03 18:32:31
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1377121 Protagonist Therapeutics Inc PTGX Pharmaceutical Preparations (2834) 980505495
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1763923 Suneel Gupta 7707 Gateway Blvd., Suite 140
Newark CA 94560
Evp Clinical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-03 30,000 $5.13 49,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.99 to $5.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  2. Includes 2,000 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2019.